Cutaneous Adverse Effects Associated with Lag-3 Inhibitor Use in Cancer Treatment: A Systematic Review
Hira Ghani(Northwestern University), Babar Rao(Rutgers, The State University of New Jersey), Samavia Khan(Rutgers, The State University of New Jersey), Khalil A. Khatri(Laser and Skin Surgery Center of New York), Erica DeCecco(Cooper Medical School of Rowan University), Nithisha Cheendalla(Rowan University), Rebecca Fliorent(Rowan University), Beth Richards(Cooper Medical School of Rowan University), Marielle Jamgochian(Rutgers, The State University of New Jersey)
Cited by 4
Related Papers
Artificial intelligence in dermatology: advancements and challenges in skin of color
|International Journal of Dermatology|2024|55
Evaluating the Efficacy of Eravacycline and Omadacycline against Extensively Drug-Resistant Acinetobacter baumannii Patient Isolates
|Antibiotics|2022|22
Combinations of Antibiotics Effective against Extensively- and Pandrug-Resistant Acinetobacter baumannii Patient Isolates
|Microorganisms|2024|21
From tugs to treatments: a systematic review on pharmacological interventions for trichotillomania
|Clinical and Experimental Dermatology|2024|2
Metastatic triple‐negative breast carcinoma mimicking melanoma: A potential diagnostic pitfall
|Journal of Cutaneous Pathology|2024|2